SHIMANO Hitoshi
- Articles
- Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features
大和田洋平; 田村孝史; 田野井智倫; 小澤佑介; 清水義夫; 久倉勝治; 松坂 賢; 島野 仁; 坂下信悟; 礒田博子; 大河内信弘
Pathol Int/68(1)/pp.12-22, 2018 - 脂肪酸の質の観点から考える2型糖尿病の新たな治療戦略～Elovl6による脂肪酸鎖長制御と糖尿病～
島野 仁
DITN/479/pp.6-6, 2018-04 - Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
Ozawa Yusuke; Tamura Takafumi; Owada Yohei; Shimizu Yosh...
WORLD JOURNAL OF GASTROENTEROLOGY/24(15)/pp.1622-1631, 2018-04 - PCSK9抑制による心血管イベントの減少
島野 仁
bios/23(I)/pp.9-10, 2018-03 - 中性脂肪代謝の基礎
菅野洋子; Shimano Hitoshi
食と医療/4(WINTER-SPRING)/pp.47-55, 2018-01 - Quantitative Relationship Between Cumulative Risk Alleles Based on Genome-Wide Association Studies and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
S Kodama; K Fujihara; H Ishiguro; C Horikawa; N Ohara; Y ...
Journal of Epidemiology/28(1)/pp.3-18, 2018-01 - Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering.
M Takanashi; Y Taira; S Okazaki; S Takase; T Kimura; CC ...
J Atheroscler Thromb./24(11)/pp.1105-1116, 2017-11 - 【脂質異常症治療の新たな展開:ペマフィブラートへの期待】 フィブラート系薬の歴史と特性 TG低下の作用メカニズム、大規模試験など
中川 嘉; Shimano Hitoshi
Progress in Medicine/37(9)/pp.1025-1031, 2017-09 - Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry
Sawada Yoshikazu; Izumida Yoshihiko; Takeuchi Yoshinori; ...
Biochemical and biophysical research communications/493(1)/pp.40-45, 2017-09 - SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.
Shimano Hitoshi; Sato R
Nat Rev Endocrinol./13(12)/pp.710-730, 2017-08 - The selective PPARα modulator K-877 efficiently activates the PPARα pathway and improves lipid metabolism in mice
Takei Kenta; Han Song-Iee; Murayama Yuki; Satoh Aoi; Oika...
Journal of diabetes investigation/8(4)/pp.446-452, 2017-07 - Critical role of CREBH-mediated induction of TGF-β2 by HCV infection in fibrogenic responses in hepatic stellate cells
Chida Takeshi; Ito Masahiko; Nakashima Kenji; Kanegae ...
Hepatology (Baltimore, Md.)/66(5)/pp.1430-1443, 2017-06 - Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering.
M Takanashi; Y Taira; S Okazaki; S Takase; T Kimura; CC ...
J Atheroscler Thromb./24(11)/pp.1105-1116, 2017-04 - Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice
Takei Kenta; Nakagawa Yoshimi; Wang Yunong; Han Song-...
Journal of pharmacological sciences/133(4)/pp.214-222, 2017-04 - II型肺胞上皮細胞の脂質代謝が肺線維症、肺気腫の病態形成に及ぼす影響
須永 浩章; 松井 弘樹; 前野 敏孝; 原 健一郎; 上野 学; 増渕 裕朗; 磯 達也; 小板橋 紀通; 松坂...
分子呼吸器病/21(1)/pp.84-87, 2017-03 - II型肺胞上皮細胞の脂質代謝が肺線維症、肺気腫の病態形成に及ぼす影響
須永浩章; 松井弘樹; 前野敏孝; 原 健一郎; 上野 学; 増渕裕朗; 磯 達也; 小板橋紀通; 松坂 賢; Shiman...
分子呼吸器病/21(1)/pp.84-87, 2017-03 - 飽和脂肪酸・コレステロール摂取制限の科学的根拠
菅野洋子; Shimano Hitoshi
動脈硬化予防/16(1)/pp.21-27, 2017-03 - 飽和脂肪酸・コレステロール摂取制限の科学的根拠
Shimano Hitoshi
動脈硬化予防/16(1)/pp.21-27, 2017-03 - 動脈硬化と栄養遺伝子制御 膜貫通型転写因子が制御する脂質代謝と動脈硬化
中川嘉; 島野 仁
実験医学/34(15)/pp.2602-2608, 2016-09 - Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression.
Kikuchi Takuya; Orihara Kana; Oikawa Fusaka; Han Song-ie...
Mol Metab./5(11)/pp.1092-1102, 2016-09 - 脂肪酸合成と臓器障害（中性脂肪代謝の分子機構と臓器障害）
松坂 賢; 島野 仁
The Lipid/27(3)/pp.212-218, 2016-07 - Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy
Osaki Yoshinori; Nakagawa Yoshimi; Miyahara Shoko; Iwasak...
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS/466(3)/pp.536-540, 2015-10 - 糖尿病多発神経障害を伴った2型糖尿病患者の重心動揺計を用いたバランス能力評価についての検討
鈴木 康裕; 矢藤 繁; 加藤 秀典; 田邉 裕基; 石川 公久; 上野 友之; 島野 仁
Congress of the Japanese Physical Therapy Association/2014(0)/p.504, 2015 - Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes
Fujihara Kazuya; HiroakiSuzuki; Sato Akira; Kodama Satoru...
J Diabetes Res/2015/p.507245, 2015 - Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Naka...
HEPATOLOGY/59(5)/pp.1791-1802, 2014-05 - more...
- Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features